https://www.foodandbeveragetimesasia.com/article/922004067-hutchmed-highlights-pivotal-phase-ii-data-for-fanregratinib-in-intrahepatic-cholangiocarcinoma-presented-at-esmo-gastrointestinal-cancers-congress
HUTCHMED Highlights Pivotal Phase II Data for Fanregratinib in Intrahepatic Cholangiocarcinoma...
phase iihighlightspivotaldataintrahepatic
https://li01.tci-thaijo.org/index.php/SRIMEDJ/article/view/23739
Expression Patterns of Selenoprotein P in Human Cholangiocarcinoma | Srinagarind Medical Journal
selenoprotein pmedical journalexpressionpatternshuman
https://portalinvestigacion.um.es/documentos/65911dcfae63c86e421b9de7?lang=en
ASO Author Reflections: The New Age of Minimally Invasive Perihilar Cholangiocarcinoma | Documents...
Universidad de Murcia research portal: researchers, research groups, publications, projects and research data.
the new ageminimally invasiveasoauthorreflections
https://pure.korea.ac.kr/en/clippings/study-findings-from-university-of-ulsan-provide-new-insights-into/
Study Findings from University of Ulsan Provide New Insights into Cholangiocarcinoma (Proteogenomic...
university of ulsanstudyfindingsprovidenew
https://hmsom.elsevierpure.com/en/publications/a-phase-ii-study-of-gemcitabine-and-capecitabine-in-advanced-chol/
A phase II study of gemcitabine and capecitabine in advanced cholangiocarcinoma and carcinoma of...
phase ii studygemcitabinecapecitabineadvancedcholangiocarcinoma
https://www.cholangio.ca/get-involved
Get in Touch | Canadian Cholangiocarcinoma Collaborative
Canadian Cholangiocarcinoma Collaborative is a partnership among patients, caregivers, oncologists and researchers which was formed to grow hope in patients...
get in touchcanadiancholangiocarcinomacollaborative
Sponsored https://www.asstok.com/enter.php?prg=1&id=robuta&t=best&ad_id=asstok_315x300_ms2.jpg
Asstok
Ready for a modern day adult dating site? Hook up online and enjoy sexting with others on AssTok. Trade private photos and videos formerly.
https://mararating.com/report/ivosidenib-for-treating-advanced-cholangiocarcinoma-with-an-idh1-r132-mutation-after-1-or-more-systemic-treatments-as-of-january-2024-market-access-risk-assessment/
Ivosidenib / tibsovo for treating advanced cholangiocarcinoma with an IDH1 R132 mutation after 1 or...
Sep 29, 2026 - As of January 2024, MARA's assessment finds Ivosidenib / Tibsovo's reimbursement risk concentrated in comparator selection.
with anivosidenibtibsovotreatingadvanced
https://veri.larvol.com/associations/ifng-l_cholangiocarcinoma_bexmarilimab
Cholangiocarcinoma - bexmarilimab - IFNG-L - LARVOL VERI
LARVOL VERI predictive biomarker evidence connecting Cholangiocarcinoma, bexmarilimab, and IFNG-L.
cholangiocarcinomaifngveri
https://www.warpnine.org.au/cholangiocarcinoma
Cholangiocarcinoma | WARPNINE
cholangiocarcinoma
https://www.ijotm.com/ojs/index.php/IJOTM/article/view/174
Cutaneous Metastasis of Cholangiocarcinoma: Report of Two Cases | Geramizadeh | Int J Organ...
Cutaneous Metastasis of Cholangiocarcinoma: Report of Two Cases
int jcutaneousmetastasischolangiocarcinomareport
https://cholangiocarcinomaaustralia.org/meet-olaparib-a-key-player-in-the-fight-against-cancer/
Meet Olaparib: A Key Player in the Fight Against Cancer - Cholangiocarcinoma Australia
Oct 13, 2024 - Discover how Olaparib, a breakthrough PARP inhibitor, enhances cancer treatment for patients with BRCA mutations. Learn more about its benefits and uses.
in themeetolaparibkeyplayer
https://pmc.ncbi.nlm.nih.gov/articles/PMC9273057/
The Landmark Series: Hilar Cholangiocarcinoma - PMC
Hilar cholangiocarcinoma (HC) is a rare and highly aggressive biliary tract neoplasm. As such, data driving management of this disease is generally not based...
the landmarkhilar cholangiocarcinomaseriespmc
Sponsored https://www.litlatinz.com/enter.php?prg=1&id=robuta&t=best&ad_id=litlatinz_315x300_phoneswap2.gif
LitLatinz
Date with some spice. Join for free to meet sexy local Latinas.
https://bascompalmerlearn.org/course/view.php?id=480
Course: Cranial Nerve 6 Palsy from Metastatic Cholangiocarcinoma | Bascom Palmer
cranial nervebascom palmercoursepalsymetastatic
https://pure.ewha.ac.kr/en/publications/a-mouse-model-of-cholestasis-associated-cholangiocarcinoma-and-tr/
A mouse model of cholestasis-associated cholangiocarcinoma and transcription factors involved in...
mouse modeltranscription factorscholestasisassociatedcholangiocarcinoma
https://oncology.pencis.com/tag/targeted-therapy-for-cholangiocarcinoma-prize/
Targeted Therapy for Cholangiocarcinoma Prize Archives - Pencis
targeted therapycholangiocarcinomaprizearchives
https://oncology.pencis.com/tag/cholangiocarcinoma-awareness-award/
Cholangiocarcinoma Awareness Award Archives - Pencis
cholangiocarcinomaawarenessawardarchives
https://kolpulse.com/kol-pulse-trial-profile-refocus
REFOCUS: Lirafugratinib Approved in FGFR2+ Cholangiocarcinoma | KOL Pulse
FGFR2 fusion/rearrangement cholangiocarcinoma: FDA approved lirafugratinib (Lyrfigtu, Elevar) Sept 23, 2026 - ORR 46%, mDOR 11.8 mo (REFOCUS, single-arm...
refocuslirafugratinibapprovedcholangiocarcinomakol
https://www.evotec.com/sciencepool/gns561-for-the-treatment-of-intrahepatic-cholangiocarcinoma
GNS561 for the Treatment of Intrahepatic Cholangiocarcinoma - Evotec
Read the publication on the GNS561 for the Treatment of Intrahepatic Cholangiocarcinoma
for thetreatmentintrahepaticcholangiocarcinomaevotec
https://www.spandidos-publications.com/10.3892/or.2015.3738?text=fulltext
Melatonin induces apoptosis in cholangiocarcinoma cell lines by activating the reactive oxygen...
Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.
cell linesreactive oxygenmelatonininducesapoptosis
https://bi.tbzmed.ac.ir/citation_report/bi-31086/crossref
Targeting immune checkpoints as a new therapeutic strategy for intra-hepatic cholangiocarcinoma
as atargetingimmunecheckpointsnew
https://murex.mahidol.ac.th/en/publications/inferior-segmentectomy-iv-a-surgical-approach-for-hilar-cholangio/
Inferior segmentectomy IV: A surgical approach for hilar cholangiocarcinoma - Mahidol University
hilar cholangiocarcinomamahidol universityinferiorsegmentectomysurgical
https://cordis.europa.eu/project/id/101280775/es
Unravelling Malignant Cholangiocyte Subpopulations that Drive Chemoresistance in Cholangiocarcinoma...
Cholangiocarcinoma (CCA) is a highly heterogeneous and aggressive group of malignant tumours arising along the biliary tree. Its incidence (~5:100,000) is...
unravellingmalignantcholangiocytesubpopulationsdrive